HDPCR™ Multi-Drug Resistance (MDR) Panel*

For further information see below

*The HDPCR™ MDR assay is for research only. Not for use in diagnostic procedures.

The most comprehensive testing in a single test for common gram-negative, gram-positive multi-drug resistance markers and toxigenic Clostridium difficile

Antibiotic resistance is a global concern; expanded antimicrobial stewardship and infection prevention efforts are needed to stop the spread

Get ahead of the problem by using a comprehensive panel for faster colonization testing and characterization of multi-drug resistant infections

HDPCR™ MDR*

Multi-Drug Resistance (MDR) Panel

Extended Spectrum β-Lactamases

CTX-M

Carbapenemases

IMP
KPC
NDM
OXA-48
VIM

Polymyxin Resistance

mcr-2

Vancomycin Resistance (Enterococci)

vanA

Toxigenic C. difficile

tcdB (C. difficile toxin B gene)
*The HDPCR™ MDR assay is for research use only. Not for use in diagnostic procedures

> Increase throughput and decrease time to identification by utilizing an extensive panel that simultaneously screens 9 targets

> Seamless integration & cost effective by utilizing existing qPCR instrumentation and standard workflow

> Streamline data analysis using cloud-based software

> Customize your lab’s needs with selective reporting analysis and scalable throughput

Key Test Specifications

Sample Type

Rectal and Perirectal Swab Specimens
Pure Colonies

Instrument Compatibility

Applied Biosystems™ 7500 Fast / Fast DX
Applied Biosystems™ QuantStudio™ 7
Applied Biosystems™ QuantStudio™ 12K Flex
Applied Biosystems™ ViiA™ 7

Run Time

< 3 Hours

# Sample Wells / # Reportable Targets

1 sample well / 9 reportable targets

Throughput

Scalable: 96-well plate format